Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 5/160 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 5/80 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - valsartan, amlodipine besilate - film coated tablet - 10/160 milligram

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

the jordanian pharmaceutical manufacturing medical equipment co. ltd. (jpm), jordan - mebeverine hydrochloride - film-coated tablet - 135 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - gramicidin, quantity: 0.25 mg/g; triamcinolone acetonide, quantity: 1 mg/g; nystatin, quantity: 100000 u/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - kenacomb is indicated for the relief of the inflammatory and pruritic manifestations of dermatoses likely to become or which are already infected.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 1 mg/g; nystatin, quantity: 100000 u/g; gramicidin, quantity: 0.25 mg/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene. kenacomb otic is only recommended for short-term use.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 90000 u/ml; triamcinolone acetonide, quantity: 0.9 mg/ml; gramicidin, quantity: 0.225 mg/ml; neomycin sulfate (equivalent: neomycin, qty 2.25 mg/ml) - ear drops, solution - excipient ingredients: polyethylene; liquid paraffin - treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene